1 News interview MRINZ director about “ground-breaking” asthma research which could more than half risk of severe exacerbations

Written By Guest User
1 in 6 New Zealanders has asthma, and many require two inhalers – a ‘preventer’ and a ‘reliever’. Increased treatment complexity has been shown to reduce adherence to that prescription – which could nullify any benefit.

1 in 6 New Zealanders has asthma, and many require two inhalers – a ‘preventer’ and a ‘reliever’. Increased treatment complexity has been shown to reduce adherence to that prescription – which could nullify any benefit.

1 News interviewed MRINZ director Professor Richard Beasley about the recent publication of ground-breaking asthma research, which showed a combination inhaler could more than half the risk of severe asthma exacerbations. This benefit came with a lower number of inhalers, less frequent doses, and a lower overall steroid burden.

The study was published in the New England Journal of Medicine.

Guest User
Previous

Trial re: oxygen use in surgery wins vital feasibility funding from Health Research Council
Next

Kānuka honey found as effective as standard anti-viral treatment for cold sores, in large-scale randomised controlled trial